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Edited by Horst FeldmannAbstract Nonsense-mediated mRNA decay (NMD) is an
mRNA surveillance pathway which ensures the rapid degrada-
tion of mRNAs containing premature translation termination
codons (PTCs or nonsense codons), thereby preventing the accu-
mulation of truncated and potentially harmful proteins. In this
way, the NMD pathway contributes to suppressing or exacerbat-
ing the clinical manifestations of speciﬁc human genetic disor-
ders. Studies in model organisms have led to the identiﬁcation
of the eﬀectors of the NMD pathway, and illuminated the mech-
anisms by which premature stops are discriminated from natural
stops, so that only the former trigger rapid mRNA degradation.
These studies are providing important insights that will aid the
development of new treatments for at least some human genetic
diseases.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The eukaryotic gene expression pathway involves a number
of interlinked steps from transcription of the genetic material
to protein synthesis, with messenger RNAs (mRNAs) being
the key intermediates in this process. The mRNA precursor
is transcribed from DNA, processed by removal of introns
and addition of the cap structure and the poly(A) tail, and
the mature mRNA is then exported to the cytoplasm where
it is translated to protein and ﬁnally degraded. It is now estab-
lished that most, if not all, of the steps of the gene expression
pathway can be regulated, allowing the expression of individ-
ual genes to be controlled.
While the complexity of eukaryotic gene expression allows
for the production of proteins to be controlled at many levels,Abbreviations: DSE, downstream sequence element; EJC, exon junc-
tion complex; NMD, nonsense-mediated mRNA decay; PTC, pre-
mature translation termination codon; SMG, suppressor with
morphological eﬀect on genitalia; UPF, up-frameshift; UTR, untrans-
lated regions
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at any step. Eukaryotic cells have evolved elaborate mRNA
quality control mechanisms that ensure the ﬁdelity of gene
expression by detecting and degrading aberrant transcripts
[1]. These quality control mechanisms (or mRNA surveillance
mechanisms) operate in both the nucleus and the cytoplasm.
For example, improperly processed mRNAs are degraded by
mRNA surveillance mechanisms in the nucleus before they
are exported [1]. In the cytoplasm, quality control mechanisms
assess the translatability of the mRNA and degrade any that
lack translation termination codons (non-stop-mediated
mRNA decay, NSD) or that have premature translation termi-
nation codons (nonsense-mediated mRNA decay, NMD),
thereby preventing the accumulation of potentially toxic pro-
tein fragments [1].
mRNA surveillance pathways act not only on aberrant
mRNAs, but also regulate the expression of naturally occur-
ring transcripts having features recognized by the surveil-
lance machineries. In this way, surveillance pathways also
contribute to the post-transcriptional regulation of gene
expression [2].
One of the best characterized mRNA quality control mech-
anisms in eukaryotes is the nonsense-mediated mRNA decay
(NMD) pathway, which rids the cell of mRNAs with prema-
ture translation termination codons (PTCs or nonsense co-
dons) [2–5]. In this review, we discuss new insights into the
molecular mechanisms of NMD gained from studies in model
organisms. These studies reveal that whilst the NMD machin-
ery is conserved, diﬀerent species have evolved diﬀerent mech-
anisms of recognizing and degrading aberrant transcripts. The
mechanism by which nonsense mRNAs are recognized impacts
on the eﬀectors as well as on the endogenous targets of this
pathway.2. Nonsense-mediated mRNA decay: a summary
Nonsense-mediated mRNA decay is triggered by premature
translation termination, which leads to the assembly on the
mRNA of what is known as a ‘surveillance complex’. The role
of the surveillance complex is to couple a premature
translation termination event to mRNA degradation by inter-
acting with both eukaryotic translation termination factors
(i.e. eukaryotic release factors 1 and 3; eRF1 and eRF3), and
with the general cellular mRNA decay machinery, thereby
accelerating degradation of the aberrant mRNA [2–5].blished by Elsevier B.V. All rights reserved.
Fig. 1. UPF1 is a conserved RNA helicase essential for NMD. UPF1
is phosphorylated at multiple serine residues. Phosphorylation of
UPF1 is catalyzed by SMG1, a phosphoinositide-3-kinase-related
protein kinase and requires UPF2 and UPF3 [11–14,19]. The dephos-
phorylation of UPF1 is mediated by SMG5, SMG6 and SMG7, three
similar, but not redundant, proteins. These proteins bind phosphor-
ylated UPF1 through speciﬁc domains, which adopt a 14-3-3-like fold
[8], and trigger UPF1 dephosphorylation by recruiting phosphatase 2A
(PP2A) [15–18].
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eﬀectors, which include three yeast (UPF1, UPF2 and UPF3:
up-frameshifts 1–3) and seven Caenorhabditis elegans proteins
(SMG1–7, suppressor with morphological eﬀect on genitalia
1–7). These eﬀectors were identiﬁed in genetic screens in Sac-
charomyces cerevisiae and C. elegans, or by homology searches
in other organisms [2–5]. They play an essential role in NMD
in all organisms in which this process has been investigated
(Table 1). The UPF1, UPF2 and UPF3 proteins (also known
as SMG-2, SMG-3 and SMG-4 in C. elegans) are conserved
in eukaryotes including S. cerevisiae, C. elegans, Drosophila
melanogaster, Homo sapiens, as well as Arabidopsis thaliana
[2–5]. There are two UPF3 paralogue genes in vertebrates
(UPF3a and UPF3b also known as UPF3 and UPF3x). These
proteins are unlikely to be redundant, because depletion of
human UPF3b, but not of UPF3a, abolishes NMD of some
mRNAs containing nonsense codons [6,7].
The additional NMD eﬀectors (SMG1, SMG5, SMG6 and
SMG7) are conserved in most multicellular organisms, but
SMG7 has no clear orthologue in D. melanogaster. SMG5,
SMG6 and SMG7 are homologous to the S. cerevisiae telome-
rase associated protein Est1p and the related protein Ebs1p,
but we do not know whether these proteins play a role in
NMD [8–10].
UPF1 is an RNA helicase whose activity is regulated
by cycles of phosphorylation and dephosphorylation, and this
requires the additional NMD eﬀectors (Fig. 1). Phosphory-
lation of UPF1 requires UPF2 and UPF3, and is catalyzed
by SMG1, a protein kinase related to phosphoinositide-
3-kinases [11–14]. Dephosphorylation of UPF1 is mediated
by SMG5, SMG6 and SMG7, three related proteins which
act as adaptors between phosphorylated UPF1 and protein
phosphatase 2A (Fig. 1) [15–19]. SMG5–7 bind phosphory-
lated UPF1 through speciﬁc domains that adopt a 14-3-3-like
fold [8]. Despite the absence of clear orthologues of SMG1 and
SMG5–7 in S. cerevisiae, both UPF1 and UPF2 are phosphor-
ylated in this organism [20]. However, the identity of theTable 1
NMD eﬀectors in the organism for which NMD has been investigated are
pathway by gene knockouts (KO) or knockdowns (KD)
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(Saccharomyces
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Whether plants have orthologues of SMG1 and SMG5–7 has not been detekinase(s) responsible for these phosphorylations and how
dephosphorylation occurs, remain to be established.
The precise mechanism by which NMD eﬀectors assemble
on mRNAs that terminate translation prematurely is not com-
pletely understood and diﬀers between species (Fig. 2) [3–5,21].
It is generally accepted that UPF1 is recruited to mRNAs by
ribosomes terminating translation prematurely. This recruit-shown as well as the phenotypes resulting from the inhibition of the
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Fig. 2. The NMD pathway. A premature translation termination codon (PTC) is deﬁned relative to the position of a downstream cis-acting signal
that varies across species [3–5]. In mammals, the cis-acting signal is an exon–exon junction marked by a group of proteins that constitute the exon
junction complex (EJC). The EJC is a multiprotein complex deposited at exon–exon boundaries during splicing (grey circle). A translation
termination event upstream of an EJC leads to the recruitment of UPF1 and SMG1 by the eukaryotic translation release factors eRF1 and eRF3.
UPF1 then interacts with UPF2, UPF3, and additional EJC proteins bound to a downstream EJC. These interactions result in the assembly of the
surveillance complex, the phosphorylation of UPF1 by SMG1 and ultimately mRNA degradation. In Saccharomyces cerevisiae, Drosophila
melanogaster and Caenorhabditis elegans the cis-acting signal is a faux 3 0 UTR [5,25,38–40]. Natural termination codons (STOP), in contrast to
PTCs, are ﬂanked by proper 3 0 UTRs marked by a speciﬁc protein or set of proteins, including the cytoplasmic poly(A)-binding protein (PABPC1),
which is thought to increase the eﬃciency of translation termination. Premature termination is ineﬃcient because the PTC lacks proximal PABPC1
and/or other factors associated with a natural 3 0 UTR. In this case, the NMD factors UPF1–3 are recruited via interactions with the eRFs. Again,
this results in the assembly of the surveillance complex, phosphorylation of UPF1 and degradation of the nonsense mRNA.
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eRF3, which form a complex with UPF1 and SMG1 [19,22].Subsequently, UPF1 interacts with UPF2 and UPF3 forming
the core of the surveillance complex. In metazoans, formation
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UPF1 phosphorylation by SMG1 [11–14,19,21,23]. Phosphor-
ylated UPF1 is then recognized by the SMG5–7 proteins
[8,15,16]. These proteins are thought to provide a molecular
link between the core of the surveillance complex and the gen-
eral cellular mRNA decay enzymes [24], which degrade the
mRNA exonucleolytically from the two ends of the transcript.
Additionally, SMG5–7 recruit protein phosphatase 2A result-
ing in UPF1 dephosphorylation [15–18]. This is likely to play a
role in the recycling of NMD eﬀectors for a new round of
NMD.
In S. cerevisiae the lack of SMG5–7 orthologues suggests
that the decay enzymes are likely to be recruited to nonsense
mRNAs via direct interactions with the UPF1:UPF2:UPF3
trimeric complex. In D. melanogaster, the absence of a clear
SMG7 orthologue together with the observation that decay
of nonsense mRNAs is initiated by endonucleolytic cleavage
near the PTC, suggest that once assembled, the surveillance
complex recruits a speciﬁc NMD endonuclease [25,26]. Finally,
as discussed below, alternative NMD pathways that are inde-
pendent of either UPF2 or UPF3 have been described in
human cells [7,27], suggesting that during evolution additional
proteins may have acquired similar functions.3. Mechanism of premature stop codon recognition in mammals
The initial step in the NMD pathway is the recognition of a
stop codon as premature. This raises the question of how a
premature stop codon is discriminated from a natural stop,
so that only the former triggers mRNA decay. Insights into
this question have been provided by the observation that the
ability of a nonsense codon to elicit mRNA degradation (i.e.
NMD) depends on its location relative to downstream
sequence elements and associated proteins [3–5].
In mammals, these downstream sequences are represented
by exon–exon boundaries (Fig. 2). Indeed, natural stops are
typically located within terminal exons, whereas destabilizing
nonsense codons lie more than 50–55 nucleotides upstream
of the last exon–exon boundary [3–5,28]. Exon–exon bound-
aries are marked by the exon junction complex (EJC), a
multiprotein complex deposited during splicing 20–24 nucleo-
tides upstream of a splice junction [29]. That the EJC provides
positional information to discriminate premature from natural
stops is supported by the observation that at least ﬁve EJC
components are required for NMD in human cells. These
include the protein RNPS1, the Y14:MAGOH heterodimer
and additional binding-partners such as the protein Barentsz
and the RNA helicase eIF4AIII [30–35]. Moreover, UPF3b
interacts with EJC proteins and is considered to be a periphe-
ral component of the EJC [29,36].
The association of UPF3b with the EJC in mammalian cells
together with its nuclear localization suggest that UPF3b is
loaded onto mRNAs within the nucleus and recruits UPF2
(which is cytoplasmic) following the export of the mRNA to
the cytoplasm [29,36,37]. When translating ribosomes encoun-
ter a stop codon upstream of an EJC, the recruitment of UPF1
by the release factors eRF1 and eRF3 [19,21], enables the
interaction of UPF1 with the UPF2 and UPF3 proteins bound
to the downstream EJC, and thus to the assembly of thesurveillance complex, phosphorylation of UPF1 by SMG1
and ultimately to mRNA degradation (Fig. 2) [19,21]. As men-
tioned above, it is possible that some EJC proteins can func-
tionally substitute for UPF2 or UPF3, because NMD
pathways independent of either of these proteins have been
described [7,27].4. Mechanism of premature stop codon recognition in
invertebrates
Recent studies in S. cerevisiae, D. melanogaster and C.
elegans have shown that in these organisms PTC-recognition
occurs independently of splicing, and thus of exon–exon
boundaries [25,38–40]. Consequently, EJC components are
not required for NMD in C. elegans and D. melanogaster, in
spite that they are conserved in these organisms [25,40].
Several models have been proposed to explain how PTCs are
discriminate from normal stops in invertebrates [3–5]. One
model proposes that mRNAs harbour loosely deﬁned down-
stream sequence elements (DSEs) with a function analogous
to that of mammalian exon junctions [3–5]. Alternative models
suggest that a generic feature of the mRNA, such as the
poly(A)-tail or a mark deposited during the cleavage and
polyadenylation reaction could provide positional informa-
tion to discriminate premature from natural stop codons
[3–5,41,42].
A third model, the ‘faux 3 0 UTR model’, proposes that pre-
mature translation termination is intrinsically aberrant be-
cause the stop codon is not in the appropriate context [5,38].
Indeed, experiments in S. cerevisiae have shown that transla-
tion termination is aberrant at premature stop codons, and
that prematurely terminating ribosomes are not released eﬃ-
ciently. Flanking the nonsense codon with a normal 3 0 UTR
abolishes this eﬀect [5,38].
According to the ‘faux 3 0 UTR model’, natural 3 0 UTRs are
marked by a speciﬁc set of proteins that inﬂuence translation
termination. Termination is eﬃcient at natural stops because
terminating ribosomes are able to interact with these 3 0
UTR-bound proteins. In contrast, translation termination
would be impaired or too slow at premature stops, because
these codons are ﬂanked by a ‘faux 3 0 UTR’ and terminating
ribosomes cannot establish the appropriate interactions
(Fig. 2). In this case, the surveillance complex is assembled,
leading to the rapid degradation of the mRNA [5,38].
A protein that characterizes natural 3 0 UTRs is the poly(A)-
binding protein (yeast Pabp1 or metazoan cytoplasmic
poly(A)-binding protein PABPC1, Fig. 2). Tethering of Pab1p
or PABPC1 downstream of a PTC leads to eﬃcient translation
termination and NMD suppression in S. cerevisiae or D. mel-
anogaster, respectively [5,38,39]. This suggests that the tethered
protein is suﬃcient to mimic a normal 3 0 UTR. This observa-
tion also indicates that the role of Pab1p (or PABPC1) in
PTC-deﬁnition is independent of 3 0-end mRNA cleavage and
polyadenylation.
How can Pabp1 (or PABPC1)-binding suppress NMD?
Pabp1 (or PABPC1) interacts with eRF3 [5,19,22,38], therefore
tethering of Pabp1 downstream of a PTC is likely to increase
the eﬃciency of translation termination and ribosome release,
thus abolishing NMD. In agreement with this model, tethering
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Fig. 3. Tethered eRF3 suppresses NMD. (A) Schematic representation
of the tethering reporter. This assay is based on the high aﬃnity
interaction between the RNA-binding peptide derived from the
bacteriophage-kN protein (kN-peptide) and an RNA hairpin known
as BoxB element. Proteins of interest fused to the kN-peptide are
coexpressed with a CAT reporter mRNA in which four BoxB (4BoxB)
elements are inserted in frame at the same position in a wild-type
reporter (CAT-wt) or a PTC-containing reporter (CAT-PTC), down-
stream of a PTC. Black boxes: CAT gene; gray boxes 5 0 and 3 0 UTRs
derived from the vector. White box: 4BoxB elements. (B,C) S2 cells
were transfected with the CAT-4BoxB reporters with or without PTC,
a transfection control and plasmids encoding the kN-peptide fusions of
the proteins indicated above the lanes. Total RNA samples were
analyzed by Northern blot (B). The levels of the CAT mRNA reporters
were normalized to the levels of the transfection control in three
independent experiments. The normalized values obtained for CAT-
PTC were divided by those obtained for CAT-wt for each protein (to
compensate for potential unspeciﬁc eﬀects of the overexpressions).
This ratio was set to 1 in cells expressing the kN-peptide alone. Mean
values ± S.D. of three independent experiments are shown (C).
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cerevisiae and D. melanogaster, albeit less eﬀectively than does
tethered Pabp1 (or PABPC1; Fig. 3) [5,38]. Pabp1 may also re-
cruit other translational regulators that stimulate translation
termination or proteins that prevent NMD when translation
terminates at the physiological stop codon.
The role of PABPC1 in NMD goes beyond providing posi-
tional information for PTC-deﬁnition because depletion of
PABPC1 from D. melanogaster cells inhibits NMD under con-
ditions in which translation eﬃciency is not aﬀected [39]. A
possible additional role for PABPC1 could be that of facilitat-
ing the recruitment of the NMD machinery. However, stable,RNA-independent interactions between PABPC1 and NMD
factors have not yet been reported, suggesting that if these
interactions occur they may be indirect or transient [39].5. Potential impact of NMD in the evolution of eukaryotic
3 0 UTRs
The observation that Pabp1 (or PABPC1)-binding down-
stream of a PTC converts it into a normal stop codon indicates
that what deﬁnes a normal stop is the proximity to the poly(A)
tail (i.e. the Pabp1 or PABPC1-binding site). If this were
the case, increasing the distance of natural stop codon to the
poly(A) tail should convert it into a PTC. This is indeed the
case: aberrant transcripts with exceptionally long 3 0 UTRs
(due to errors in 3 0 end-processing) are regulated by NMD
in S. cerevisiae [41]. Similarly, in D. melanogaster natural stops
can be made to trigger NMD by increasing 3 0 UTR length [39].
Consistent with the possibility that stop codons are deﬁned
as premature or natural depending on the distance to the
poly(A) tail, most S. cerevisiae 3 0 UTRs are homogeneous in
length (ca. 100nt) [5]. However, in contrast to yeast, in multi-
cellular organisms 3 0 UTR length ranges from a few to several
thousand nucleotides, and a large proportion of naturally
occurring transcripts with exceptionally long 3 0 UTRs are
not NMD substrates [39,43]. This suggests that some of these
3 0 UTRs may have evolved features to avoid NMD.
There are several mechanisms by which mRNAs with long 3 0
UTRs may escape NMD. For example, inherently unstable
mRNAs are insensitive to a further acceleration of their decay
by NMD [39]. Alternatively, long 3 0 UTRs may have sequence
elements that are folded via RNA–RNA or RNA–protein
interactions into structures that bring PABPC1 into close
proximity with the natural stop. In this case, proximity to
PABPC1 will not be directly correlated to the length in
nucleotides between the natural stop and the poly(A) tail.
An alternative mechanism to confer resistance to NMD may
involve the presence of mRNA stabilizing elements that pre-
vent degradation directly. Sequence elements that antagonize
NMD have been reported in viral and S. cerevisiae transcripts.
A sequence element that stabilizes unspliced Rous sarcoma
virus RNAs also inhibits NMD when located downstream of
a PTC [44]. The S. cerevisiae PGK1, GCN4 and YAP1 mRNAs
have sequence elements that prevent NMD in a heterologous
context when positioned downstream of a PTC [45].
The eﬀects of the S. cerevisiae stabilizing elements are med-
iated by the RNA-binding protein PUB1 [45]. It is unclear
whether PUB1 prevents decay or increases the eﬃciency of
translation termination at nonsense codons located upstream
of its binding site, but these two modes of action could be
envisaged for diﬀerent RNA-binding proteins. Immunity or
susceptibility to NMD could then be regulated if these proteins
were to be expressed under speciﬁc physiological conditions or
in a tissue-speciﬁc manner. In this way, NMD could contribute
to changes in gene expression in response to altered physiolog-
ical conditions or in speciﬁc tissues.
The existence of a mechanism of PTC-recognition based on
the position of the stop relative to the poly(A) tail, together
with the observation that natural stops are redeﬁned as prema-
ture by increasing 3 0 UTR length suggests that NMD is likely
2850 I. Behm-Ansmant et al. / FEBS Letters 581 (2007) 2845–2853to present a selective constraint on the evolution of eukaryotic
3 0 UTRs, so that the increase in 3 0 UTR lengths to accommo-
date regulatory elements and miRNA-binding sites in multi-
cellular organisms must have co-evolved with the acquisition
of features to suppress NMD.6. Evolution of the NMD pathway
The comparison of the NMD pathway in mammalian cells
and invertebrates suggests that the mechanism by which non-
sense codons are deﬁned changed during evolution from a
more ancestral PABPC1-dependent mode to a predominantly
EJC-dependent mode [2]. However, recent studies in plants
have challenged this view. Indeed in Nicotiana tabacum leaves,
both long 3 0 UTRs and exon–exon boundaries elicit eﬃcient
NMD when inserted downstream of a stop codon, indicating
that these two mechanisms were present in the common ances-
tors of extant eukaryotes [46,47].
In agreement with this, examples in which PTCs are recog-
nized in mammals in the absence of downstream EJCs have
been described ([48] and references therein), although steady-
state mRNA levels are in general only moderately aﬀected in
these cases. This raises the question of whether the two
mechanisms of NMD (i.e. splicing-dependent and PABPC1-
dependent) still coexist in mammals and perhaps in other
eukaryotes.
It has been argued that the major mechanism of PTC-rec-
ognition in eukaryotes is PABPC1-dependent and that the
role of EJC components is to enhance NMD [48]. However,
the observation that exon–exon boundaries elicit NMD when
located downstream of stop codons in mammals and N. taba-
cum, but not in S. cerevisiae, C. elegans and D. melanogaster,
points to the existence of two independent mechanisms of
PTC-recognition (i.e. splicing dependent and splicing-inde-
pendent). In agreement with this, available evidence indicates
that PABPC1 is dispensable for NMD in human cells, pro-
vided that the PTC is located upstream of an exon–exon
boundary [49].
One consequence of the splicing-dependent mechanism for
PTC-deﬁnition in mammals is the requirement of EJC compo-
nents for NMD. These include the human proteins Y14,
MAGOH, eIF4AIII, Barentsz and RNPS1 [30–35]. Their
orthologues in C. elegans and D. melanogaster are not required
for NMD [25,40]. Moreover, there are no clear orthologues of
these proteins in S. cerevisiae. In this context, it would be of
interest to determine whether these proteins are required for
NMD in plants or whether EJC components have been
co-opted only by the mammalian NMD machinery.
The splicing-dependent mechanism for PTC-recognition has
also important consequences for the evolution of the NMD
pathway. Indeed, the existence of an intermediate step in the
assembly of the surveillance complex in which NMD eﬀectors
interact with EJC components (Fig. 2), may have created the
opportunity for EJC proteins to functionally substitute for
UPF2 or UPF3 as reported by Gehring et al. and Chan
et al. [7,27]. In turn, the release of functional constraints on
NMD eﬀectors may have facilitated the acquisition of addi-
tional functions. Indeed, mammalian UPF1, SMG1 and
SMG5–7 have been implicated in cellular processes distinct
from NMD [2,9,10,50–52].7. Functional diversiﬁcation of the eﬀectors of NMD
In human cells, Mendell et al. reported that UPF1 targets
are also regulated by UPF2 [53]. In contrast, Gehring et al.
identiﬁed endogenous transcripts that are regulated by UPF1
but remain unaﬀected in cells depleted of UPF2 [27]. Similarly,
Chan et al. identiﬁed NMD substrates that are dependent on
UPF1 and UPF2 but not UPF3 [7]. Based on these and addi-
tional observations, Gehring et al. and Chan et al. proposed
the existence of alternative branches of the NMD pathway in
human cells, namely a UPF2-independent and a UPF3-inde-
pendent pathway [7,27], which is in agreement with the analy-
sis of expression proﬁles in human cells depleted of UPF2 or
UPF3 [2,7,27]. Indeed, UPF2 or UPF3 regulate only a subset
of UPF1 targets and vice versa [2,7,27].
The lack of genome-wide information on genes regulated by
the additional components of the NMD machinery in human
cells leaves open the question of whether transcripts regulated
exclusively by UPF1, UPF2 or UPF3 represent NMD targets,
or rather reﬂect transcripts regulated by these proteins by
mechanisms distinct from NMD, providing evidence for a
functional diversiﬁcation of these NMD eﬀectors. That
UPF1, UPF2 and UPF3 might have partially non-overlapping
functions is further supported by the observation that human
cells depleted of UPF1 are arrested early in S-phase, depletion
of UPF2 has no apparent phenotype, and depletion of UPF3b
aﬀects cell proliferation (Table 1) [7,50].
Evidence that UPF1 does indeed have additional roles
already exists. UPF1 can be recruited to the 3 0 UTR of speciﬁc
transcripts via interactions with Staufen1 (a double-stranded
RNA-binding protein), and promotes mRNA degradation by
a mechanism not requiring UPF2 or UPF3 [51]. Moreover,
UPF1 is implicated in the degradation of histone mRNAs.
In this case, UPF1 is recruited to the conserved stem–loop
structure present at the 3 0-end of histone mRNAs via interac-
tions with the stem–loop-binding protein (SLBP) [52]. These
observations raise the possibility that other RNA-binding
proteins might act in a similar way.
In contrast to the situation in human cells, gene expression
proﬁles in S. cerevisiae and D. melanogaster cells depleted of
NMD eﬀectors are strikingly similar, making it unlikely that
these proteins have acquire additional roles in mRNA metab-
olism in these organisms [2,43,54]. However, it remains possi-
ble that NMD eﬀectors have acquired specialized functions
that do not aﬀect steady-state mRNA levels, and thus that
are not revealed by microarray analysis.8. NMD regulates a signiﬁcant fraction of the transcriptome
Gene expression proﬁling of S. cerevisiae, D. melanogaster
and human cells depleted of essential NMD factors has
allowed the identiﬁcation of a cohort of transcripts regulated
by NMD. These studies revealed that NMD regulates the
expression of approximately 3–10% of the transcriptome
[2,43,53,54].
As expected, aberrant mRNAs with PTCs are found
amongst NMD targets. These include ineﬃciently spliced
mRNAs that are exported to the cytoplasm with intronic
sequences, alternatively spliced mRNA isoforms with PTCs,
and transcripts derived from pseudogenes and transposable
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unproductively rearranged immunoglobulin and T-cell recep-
tor genes also represent an important physiological class of
NMD substrates [2]. Indeed, about two thirds of such recom-
bination events result in frame-shifted genes whose transcripts
are degraded by NMD [2–5,7].
In addition to PTC-containing mRNAs, a large set of ‘error-
free’ transcripts is also regulated by NMD [2,43,53,54]. These
‘error free’ NMD targets represent a heterogeneous group of
mRNAs and include (1) mRNAs with upstream open reading
frames (uORFs) in the 5 0 untranslated region (UTRs); (2)
mRNAs undergoing ‘‘leaky-scanning’’ for translation initia-
tion; (3) mRNAs regulated by programmed frameshifting;
(4) mRNAs with selenocysteine codons; and (5) mRNAs regu-
lated by stop codon readthrough.
Analyses of the gene ontology terms associated with tran-
scripts regulated by NMD reveal that although some fall into
functional categories that are over-represented relative to the
proportion in the genome, it is the diversity of functional cat-
egories that is most striking, indicating that NMD post-trans-
criptionally regulates a broad range of cellular processes
[2,43,53,54].
Strikingly, with few exceptions, the majority of NMD tar-
gets in D. melanogaster are not orthologues of genes regulated
by NMD in S. cerevisiae or human cells, indicating that the
repertoire of genes targeted by NMD is not conserved [2,43].
This lack of conservation could be explained in part by the dif-
ferent mechanism of PTC-recognition across species. For in-
stance, human transcripts containing introns at least 50
nucleotides downstream of the natural stop are degraded by
NMD. These transcripts are not NMD substrates in S. cerevi-
siae and D. melanogaster.
One group of orthologous transcripts commonly regulated
in the three organisms includes D. melanogaster SMG5 and
SMG6, human SMG5 and S. cerevisiae Ebs1p and Est1p
(which share a common domain organization with SMG5–7
[8–10]). The regulation of SMG5 by NMD both in human
and D. melanogaster, suggests the existence of a conserved
feedback mechanism [2,7,43].
In addition to EBS1 and EST1, ﬁve genes involved in telo-
mere maintenance are regulated by NMD in S. cerevisiae,
including EST2, EST3, STN1, YKu70 and TEL1 [55,56]. The
regulation of genes involved in telomere maintenance by
NMD has functional implications as, in S. cerevisiae, inhibi-
tion of NMD results in telomere shortening and de-repression
of silenced telomeric loci [55,56]. Furthermore, ATM (involved
in telomere maintenance and DNA repair) is regulated by
NMD in D. melanogaster [2,43]. Taken together with recent re-
ports implicating human UPF1, SMG5 and SMG6 in telome-
rase function [9,10], this suggests that the role of NMD in
regulating the expression of genes involved in telomere mainte-
nance is conserved.9. Evolutionary diversiﬁcation of the biological role of NMD
NMD components are not essential in yeast. Similarly, inhi-
bition of the NMD pathway in C. elegans leads to viable
worms, albeit with defects in the male bursa and the hermaph-
rodite vulva [3–5]. Thus, in S. cerevisiae and C. elegans, NMD
is not essential at the cellular level (Table 1). In contrast, UPF1and UPF2 are essential for larval development in D. melano-
gaster [57]. The NMD pathway is also required at the cellular
level, because cells depleted of UPF1 and UPF2 are arrested at
the G2/M-phase of the cell cycle, and cell proliferation is im-
paired by depletion of the additional NMD eﬀectors [43]. Sim-
ilarly, UPF1 is also required for cell viability in mice as UPF1
null mice die early in embryonic development and attempts to
establish homozygous UPF1/ ES cells have also failed [58].
Consistently, depletion of UPF1, but not of UPF2, from
human cells inhibits cell cycle progression (Table 1) [50]. In
A. thaliana UPF1 is also an essential gene, and mutant alleles
of this gene have pleiotropic eﬀects [47], suggesting that like in
animals, the NMD pathway in plants regulates mRNAs with
functions in a broad range of cellular processes.
Two mechanisms are likely to contribute to the phenotypic
diﬀerences observed across species when the NMD pathway
is inhibited: one is the lack of conservation of the targets of
the pathway; the second is the functional diversiﬁcation of
NMD eﬀectors, which appears to have happened at least in
mammals.10. NMD suppresses or exacerbates the phenotypes associated
with speciﬁc genetic disorders
About 30% of inherited genetic disorders are caused by
nonsense mutations or frameshifts, which generate nonsense
codons. Transcripts derived from the mutant alleles are
degraded by the NMD pathway, generally leading to a reces-
sive mode of inheritance, as the wild-type protein from the sec-
ond functional allele is able to compensate, at least in part, for
the absence of the nonsense-containing transcript. In some
cases, the nonsense transcript escapes NMD, resulting in the
production of a truncated protein, and this may lead to a dom-
inant genetic defect. This phenomenon has been shown for the
diﬀerent forms of b-thalassaemia, where some mutations cause
a mild, recessive phenotype, while others result in dominantly
inherited diseases due to the accumulation and toxic precipita-
tion of insoluble globin chains [59]. Moreover, diﬀerent pheno-
types have been observed for the same mutation in diﬀerent
individuals, suggesting that NMD eﬃciency is subject to indi-
vidual variations [59]. Other diseases with dominant and reces-
sive forms due to NMD eﬃciency are retinitis pigmentosa, von
Willebrand disease and factor X deﬁciency [59].
NMD also protects the organism from the eﬀects of acquired
mutations, e.g. during tumour progression. Transcripts of sev-
eral mutant forms of the tumour suppressor proteins BRCA1,
p53 and Wilms tumour (WT1) have been shown to be elimi-
nated by NMD. These mutations would convert the tumour
suppressors into dominant-negative oncoproteins if the tran-
scripts were not eliminated by NMD. Indeed, it has been
shown that the expression of the corresponding truncated pro-
teins from intronless cDNAs (which are immune to NMD in
mammals), leads to increased tumourogenicity, cell survival
and resistance to chemotherapy [59]. Hence, NMD protects
heterozygous carriers of these mutations from developing can-
cer, as long as the wild-type allele remains intact.
In the examples described above, NMD acts as a protective
surveillance mechanism, and increasing NMD eﬃciency may
be beneﬁcial in these cases. However, in some genetic diseases,
where a nonsense mutation targets the mutant transcript for
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to the cell than the expression of the truncated protein would
be. This applies to cases in which the truncated protein does
not have dominant-negative eﬀects, and is at least partially
functional. Attempts to inhibit NMD in order to restore pro-
tein expression levels have been made as a tentative treatment
for some genetic diseases (e.g. cystic ﬁbrosis, Duchenne muscu-
lar dystrophy, Hurler syndrome and X-linked nephrogenic dia-
betes insipidus) [59].
Aminoglycoside drugs such as gentamycin, which promote
stop codon suppression and thus inhibit NMD, have been used
to restore expression of nonsense transcripts. Local adminis-
tration of gentamycin has yielded some promising results,
e.g. in alleviating the symptoms of cystic ﬁbrosis. A major
problem associated with the use of this approach is the low eﬃ-
cacy and the secondary eﬀects on normal protein production
and function. Therefore, approaches targeting NMD eﬀectors
speciﬁcally would be more suitable. The possibility that alter-
native NMD pathways have evolved, and that not all NMD
eﬀectors have essential biological functions opens up the
potential for approaches targeting speciﬁc non-essential
NMD components.11. Concluding remarks
Eﬀectors of theNMDpathway are being explored as potential
therapeutic targets in order to regulate the expression
of mutated genes in a subset of human genetic disorders.
Understanding the mechanism underlying NMD is therefore
of critical importance. Studies in model organisms led to the
identiﬁcation of the major players in this pathway, but our
understanding of their precise molecular function is still rudi-
mentary. Moreover, information on how the activity of these
proteins can be subject to directed regulation is lacking. Further-
more, whether alternative NMD pathways have evolved in
higher eukaryotes and whether NMD eﬀectors acquired addi-
tional functions need to be established before therapeutic
strategies targeting NMD eﬀectors can be envisaged.
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